Variable activation of the NF-κB pathway could account for the high interpatient variability of IL21R expression that was reported by de Totero et al [9] and could also explain the induction of IL21R in CLL cells following CD40 ligation. This evidence concerns the gene CD40 and B-cell chronic lymphocytic leukemia.